Analyze Your Search

Hints:

  • Action links for each search result record
    • Bookmark: Allows you to Bookmark the page for easy future retrieval 
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • More Info: Shows full summary of content record
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Follow" button to the right of the search box. 
Breast Cancer
  Follow Topic   Edit Search
Your search returned 36 results
from the time period: last 30 days.
Sort by Relevance / Date Group By Journal / No Grouping
The Cochrane database of systematic reviews 
... control and side effects AbstractText: To assess the effects of tumour bed boost radiotherapy after breast-conserving surgery and whole-breast irradiation for the treatment of breast cancer AbstractText: We searched the Cochrane Breast Cancer Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL ... Randomised controlled trials comparing the addition and the omission of breast cancer tumour bed boost radiotherapy AbstractText: Two review authors (IK and CW ...
Oncology (7)
Breast Neoplasms (4), more mentions
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 
Patients and Methods Patients in NSABP Protocol B-31 received anthracycline and taxane chemotherapy with or without trastuzumab for adjuvant treatment of node-positive, human epidermal growth factor receptor 2-positive early-stage breast cancer. A long-term follow-up assessment was undertaken for patients who were alive and disease free, which included measurement of left ventricular ejection fraction by ...
Oncology (4), Cardiovascular Diseases (1), Endocrine Disorders (1)
Neoplasms (2), Breast Neoplasms (2), Heart Diseases (1), more mentions
Trends in cancer 
Abstract: Breast cancer is a heterogeneous disease, and stratification of tumors is paramount ... While it is common to stratify and treat breast tumors as a single entity, insights from studies on intratumoral heterogeneity and cancer stem cells raise the possibility that multiple breast cancer subtypes may coexist within a tumor ...
Oncology (7)
Breast Neoplasms (6), Neoplasms (5), more mentions
Clinical cancer research : an official journal of the American Association for Cancer Research 
Abstract: Background: Breast cancer patients who do not respond to neoadjuvant therapy have a poor prognosis ... Here we report characterization of breast cancer patient-derived xenografts (PDX) largely generated from residual tumors following neoadjuvant chemotherapy ... from residual disease following neoadjuvant chemotherapy, and 24 were from triple-negative breast cancer (TNBC.
Oncology (5)
Neoplasms (6), Breast Neoplasms (4), Residual Neoplasm (1), more mentions
The New England journal of medicine 
... the absolute risk of distant recurrence among patients with T1N0 breast cancer was 10% for low-grade disease, 13% for moderate-grade ... disease; the corresponding risks of any recurrence or a contralateral breast cancer were 17%, 22%, and 26%, respectively AbstractText: After 5 years of adjuvant endocrine therapy, breast-cancer recurrences continued to occur steadily throughout the study period from ...
Oncology (10)
Neoplasms (8), Breast Neoplasms (6), more mentions
Proceedings of the National Academy of Sciences of the United States of America 
Abstract: Proinflammatory signaling pathways are commonly up-regulated in breast cancer. In estrogen receptor-negative (ER(-)) and triple-negative breast cancer (TNBC), nitric oxide synthase-2 (NOS2) and cyclooxygenase-2 (COX2) have been ... further explore these findings by investigating the impact of their coexpression on breast cancer survival... Keyword: breast cancer.
Oncology (6)
Breast Neoplasms (5), Neoplasms (3), more mentions
Cell reports 
Abstract: Therapies targeting epidermal growth factor receptor (EGFR) have variable and unpredictable responses in breast cancer. Screening triple-negative breast cancer (TNBC) patient-derived xenografts (PDXs), we identify a subset responsive to EGFR inhibition by gefitinib, which displays heterogeneous expression of wild-type EGFR... Keyword: breast cancer. Keyword: cell hierarchy.
Oncology (4)
Neoplasms (4), Breast Neoplasms (4), more mentions
The New England journal of medicine 
CitationSubset: AIM. CitationSubset: IM. DescriptorName: Breast Neoplasms. DescriptorName: Carcinoma, Ductal. DescriptorName: Female. DescriptorName: Humans. DescriptorName: Middle Aged. DescriptorName: Neoplasm Invasiveness. DescriptorName: Nipples. DescriptorName: Paraneoplastic Syndromes. DescriptorName: Skin. DescriptorName: Skin Pigmentation.
Oncology (2)
Breast Neoplasms (2), Neoplasm Invasiveness (1), Paraneoplastic Syndromes (1), more mentions
BMJ (Clinical research ed.) 
DescriptorName: Breast Neoplasms... platform).Participants 70 563 cases of cancer (22 898 prostate cancer, 15 748 breast cancer, 12 537 lung cancer, 11 488 colorectal cancer, 4369 ovarian cancer, 1896 pancreatic cancer ... to 1.10) for colorectal cancer, 1.05 (0.89 to 1.24) for breast cancer, 0.89 (0.77 to 1.02) for prostate cancer, and 1.03 (0.87 ...
Oncology (21)
Neoplasms (8), Colorectal Neoplasms (4), Prostatic Neoplasms (4), more mentions
The Cochrane database of systematic reviews 
... addition to anti-cancer treatment: (i) in women with early breast cancer (EBC); (ii) in women with advanced breast cancer without bone metastases (ABC); and (iii) in women with metastatic breast cancer and bone metastases (BCBM) AbstractText: In this review update, we searched Cochrane Breast Cancer's Specialised Register, CENTRAL, MEDLINE, Embase, the World Health Organization's International ...
Oncology (9)
Breast Neoplasms (8), Bone Resorption (1), Neoplasms (1), more mentions
The Lancet. Oncology 
... after trastuzumab-based adjuvant therapy in women with HER2-positive breast cancer... 3c (modified to stage 2-3c in February, 2010) operable breast cancer, who had completed neoadjuvant and adjuvant chemotherapy plus trastuzumab with ... given continuously for 1 year, unless disease recurrence or new breast cancer, intolerable adverse events, or consent withdrawal occurred.
Oncology (6)
Breast Neoplasms (6), more mentions
Nature 
Abstract: Breast cancer risk is influenced by rare coding variants in susceptibility genes ... However, much of the genetic contribution to breast cancer risk remains unknown... report the results of a genome-wide association study of breast cancer in 122,977 cases and 105,974 controls of European ... overlap between candidate target genes and somatic driver genes in breast tumours.
Oncology (7)
Breast Neoplasms (7), more mentions
Journal of the National Cancer Institute 
DescriptorName: Breast Neoplasms... AbstractText: Early-stage breast cancer is among the most prevalent and costly malignancies treated in ... Adjuvant radiotherapy after lumpectomy represents a substantial portion of breast cancer expenditures... followed women who were treated with lumpectomy for early-stage breast cancer... metastasis and treatment cost AbstractText: For women with early-stage breast cancer requiring adjuvant radiotherapy, HF-WBI is cost-effective compared with ...
Oncology (7)
Breast Neoplasms (6), Neoplasms (1), more mentions
PloS one 
... is associated with reduced imaging resolution in the detection of breast cancer... clinical data to produce a diagnostic score that reliably detects breast cancer (BC) as an adjunctive tool to imaging... to be impacted by breast density; it can effectively detect breast cancer in women with dense and non-dense breasts alike.
Oncology (5)
Breast Neoplasms (5), Neoplasms (1), more mentions
Cancer cell 
... HIF target gene, in CD8(+) T cells accelerated tumorigenesis while also altering vascularization. Analyses of human breast cancer showed inverse correlations between VEGF-A expression and CD8(+) T cell infiltration, and a link between T cell infiltration and vascularization. These data demonstrate that the HIF-1α/VEGF-A axis is an essential aspect of tumor immunity Keyword: HIF transcription factors.
Oncology (1)
Neoplasms (7), Neoplastic Cell Transformation (1), Hypoxia (1), more mentions
Nature communications 
... ichorCNA, software that quantifies tumor content in cfDNA from 0.1× coverage whole-genome sequencing data without prior knowledge of tumor mutations. We apply ichorCNA to 1439 blood samples from 520 patients with metastatic prostate or breast cancers. In the earliest tested sample for each patient, 34% of patients have ≥10% tumor-derived cfDNA, sufficient for standard coverage whole-exome sequencing.
Neoplasms (9), more mentions
Brachytherapy 
... of-care treatment for patients with ductal carcinoma in situ and early-stage invasive breast cancer... techniques to deliver APBI AbstractText: Members of the American Brachytherapy Society with expertise in breast cancer and breast brachytherapy in particular created an updated guideline for appropriate patient selection based on an ... Keyword: Breast cancer.
Oncology (3)
Breast Neoplasms (3), Noninfiltrating Intraductal Carcinoma (2), Neoplasms (1), more mentions
Annals of surgical oncology 
... Electron intraoperative radiotherapy (IORT) can be used during breast conserving surgery to treat early-stage invasive breast cancer... recurrence rate was 2.7% (range 1.9-3.7%) AbstractText: According to the published literature, the rate of breast cancer local recurrence after electron IORT was 0.02% per person-month, with an adjusted 5-year recurrence ...
Oncology (4)
Breast Neoplasms (3), more mentions
Nature communications 
Abstract: Metastatic breast cancer remains challenging to treat, and most patients ultimately progress on therapy... Here, we track the genetic and phenotypic subclonal evolution of four breast cancers through years of treatment to better understand how breast cancers become drug-resistant. Recurrently appearing post-chemotherapy mutations are rare. However, bulk and single-cell RNA sequencing reveal acquisition of malignant phenotypes ...
Oncology (5)
Neoplasms (5), Breast Neoplasms (1), more mentions
British journal of sports medicine 
Physical activity was associated with lower risk of seven cancer sites (colon, breast, endometrial, lung, oesophageal, pancreas and meningioma. Only colon (a protective association with recreational physical activity) and breast cancer (a protective association with overall physical activity) were supported by ... Physical activity is associated with a lower risk of several cancers, but only colon and breast cancer associations were supported by strong or highly suggestive evidence, respectively ...
Oncology (12)
Neoplasms (9), Meningioma (2), Breast Neoplasms (2), more mentions
1 2  | Next Page»